Cannabis Law Report

MAY 29, 2022

Celebrated author Michael Pollan has published two bestselling books on the topic: How to Change Your Mind and This is Your Mind on Plants. FDA granted Breakthrough Therapy designation for Spravato in 2013 and ultimately approved it for adults who have not responded to treatment after trying other antidepressant medications.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. Over 1,500 people from around the world attended MAPS’ Psychedelic Science 2013 conference in Oakland, CA. Rick Doblin, Ph.D.,

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

SMPL

MAY 26, 2020

“There was a strong sense that this was really going to be something, if when people use these strains they have any kind of experience like the mice did in the laboratories,” said Martin Lee, a writer who at the time had been finishing a book about the social history of marijuana for Simon & Schuster.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

Cannabis Law Report

NOVEMBER 24, 2021

There was one case study and one book review during this period. Legitimacy framings occur in at least three articles a year between 2013 and 2018 and are most predominant in 2014 and 2019 with a total of five articles in those years. MJA, 16 December 2013). upcoming seminars). 17), Medical Journal of Australia ( n ?

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Harris has written a variety of books that touch on the topics of consciousness, spirituality, and psychedelics. Rick Doblin, Ph.D,

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

SpeedWeed

SEPTEMBER 16, 2021

Many cities have decriminalized psychedelics, and the state of Oregon has decriminalized all drugs and is currently setting up a framework for administering psilocybin in a clinical setting. A clinical trial on MDMA is set to finish in 2022, which could lead to FDA approval.

Education 86

Education Decriminalization Research and Development Clinical Trials 86